Eli Lilly And Company

This study tests a drug called muvalaplin in about 10,450 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease and stroke. Participants either have had a prior heart attack, stroke, or artery procedure, or are at high risk for a first event. The goal…

This early-stage study is testing the safety of a new drug called LY3954068 for people with early Alzheimer's disease. The drug is injected into the spinal fluid. Researchers will measure how much of the drug gets into the body and check its effect on a brain protein linked to Al…

This study is testing whether a weekly injection called retatrutide can help reduce chronic low back pain in adults who have obesity or are overweight. The 80-week trial will compare the drug against a placebo in 586 participants to see if it improves pain and leads to weight los…